Delivery Order SPE2DB20D7059-SPE2DB24FQGU3

Award Date 6/13/24
Potential Completion Date 6/14/24
Potential Value $2.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of the ROTATEQ vaccine, a pharmaceutical product, to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The contract is a Delivery Order with a Firm Fixed Price of $4,307.76 and a completion date of June 11, 2024. The contract is not designated as a set-aside. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award is for the delivery of ROTATEQ vaccine, a 2ml vaccine, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price of $2,741.22 and a completion date of February 19, 2025. The contract is not set aside for any specific business type. Amerisourcebergen Drug Corp is the prime contractor and holds an Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,265.40, is for the delivery of the ROTATEQ vaccine, a 2-milliliter treatment. This is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. The IDC, valued at up to $999,999,999.00, serves...
This federal contract award is for the supply of ROTATEQ vaccine in 2 ml doses to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, and has a ceiling value of $4,795.55. The contract is a delivery order with a firm fixed price, and the period of performance is through November 19, 2024. The award is not associated with a set-aside designation, indicating open competition. Amerisourcebergen holds a...
The federal contract award described is for the supply of ROTATEQ vaccine, a rotavirus vaccine, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, awarded to AmerisourceBergen Drug Corp, is a $4,730.25 firm fixed-price delivery order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical. The IDC, valued at $999,999,999, serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support...
This federal contract award from the Defense Logistics Agency (DLA) is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of the ROTATEQ vaccine in 2 milliliter volumes. The firm-fixed-price Delivery Order is valued at $2,131.20 and has a completion date of February 11, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as the...
This federal contract award, valued at $2,499.85, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract provides for the delivery of the ROTATEQ vaccine, a 2-milliliter vial, to support military healthcare programs. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC, valued at up to...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of the ROTATEQ vaccine, a 2-milliliter vaccine, with a ceiling value of $5,764.05 and a completion date of August 1, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for...
This federal contract award, valued at $1,249.56, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the provision of the ROTATEQ vaccine in 2 ml doses. The contract is a delivery order, with a firm fixed price pricing type, and has an ultimate completion date of June 25, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with DLA Troop Support Medical, valued up to...
This federal contract award, valued at $2,524.05, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of the ROTATEQ vaccine, a 2ml vaccine product, with an ultimate completion date of November 12, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at...
  • SPE2DB20D7059
    Indefinite Delivery Contract
  • SPE2DB20D7059-SPE2DB24FQGU3
    Delivery Order

This federal contract award is for the delivery of the ROTATEQ vaccine in 2 mL doses to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The prime contractor for this $2,627.65 firm fixed-price delivery order is Amerisourcebergen Drug Corp, a major pharmaceutical distributor that holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a wide range of medications and medical supplies to the Department of Defense globally. This delivery order does not have a set-aside designation, indicating it was awarded through full and open competition. Amerisourcebergen, through its Corporate Office Division, leverages its extensive pharmaceutical supply chain to fulfill government contracts, providing critical medical products and treatments to support military healthcare programs.

Generated 9/12/24, 11:00 AM